Cargando…
Association of DNA Methylation at CPT1A Locus with Metabolic Syndrome in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Study
In this study, we conducted an epigenome-wide association study of metabolic syndrome (MetS) among 846 participants of European descent in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN). DNA was isolated from CD4+ T cells and methylation at ~470,000 cytosine-phosphate-guanine dinucleo...
Autores principales: | Das, Mithun, Sha, Jin, Hidalgo, Bertha, Aslibekyan, Stella, Do, Anh N., Zhi, Degui, Sun, Dianjianyi, Zhang, Tao, Li, Shengxu, Chen, Wei, Srinivasan, Sathanur R., Tiwari, Hemant K., Absher, Devin, Ordovas, Jose M., Berenson, Gerald S., Arnett, Donna K., Irvin, Marguerite R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726462/ https://www.ncbi.nlm.nih.gov/pubmed/26808626 http://dx.doi.org/10.1371/journal.pone.0145789 |
Ejemplares similares
-
Lipid changes due to fenofibrate treatment are not associated with changes in DNA methylation patterns in the GOLDN study
por: Das, Mithun, et al.
Publicado: (2015) -
Metabolic and inflammatory biomarkers are associated with epigenetic aging acceleration estimates in the GOLDN study
por: Irvin, Marguerite R., et al.
Publicado: (2018) -
Genomics of Post-Prandial Lipidomic Phenotypes in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Study
por: Irvin, Marguerite R., et al.
Publicado: (2014) -
An Exome-Wide Sequencing Study of the GOLDN Cohort Reveals Novel Associations of Coding Variants and Fasting Plasma Lipids
por: Geng, Xin, et al.
Publicado: (2019) -
A 6-CpG validated methylation risk score model for metabolic syndrome: The HyperGEN and GOLDN studies
por: Hidalgo, Bertha A., et al.
Publicado: (2021)